ANTARES PHARMA INC - COM (ATRS)

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
68,894,800
Share change
+22,032,170
Total reported value
$143,297,965
Put/Call ratio
15%
Price per share
$2.08
Number of holders
88
Value change
+$45,560,135
Number of buys
62
Number of sells
19

Institutional Holders of ANTARES PHARMA INC - COM (ATRS) as of Q2 2015

As of 30 Jun 2015, ANTARES PHARMA INC - COM (ATRS) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,894,800 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, Broadfin Capital, LLC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, GREAT POINT PARTNERS LLC, STATE STREET CORP, KINGDON CAPITAL MANAGEMENT, L.L.C., and WILLIAM HARRIS INVESTORS INC. This page lists 88 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.